nodes	percent_of_prediction	percent_of_DWPC	metapath
Triflupromazine—CHRM2—Dimenhydrinate—atopic dermatitis	0.182	0.32	CbGbCtD
Triflupromazine—BCHE—Triamcinolone—atopic dermatitis	0.0937	0.165	CbGbCtD
Triflupromazine—Dimetacrine—Diphenhydramine—atopic dermatitis	0.0929	0.224	CrCrCtD
Triflupromazine—Imipramine—Diphenhydramine—atopic dermatitis	0.0891	0.215	CrCrCtD
Triflupromazine—CHRM2—Diphenhydramine—atopic dermatitis	0.0887	0.156	CbGbCtD
Triflupromazine—Promethazine—Diphenhydramine—atopic dermatitis	0.0824	0.199	CrCrCtD
Triflupromazine—Alimemazine—Diphenhydramine—atopic dermatitis	0.0809	0.195	CrCrCtD
Triflupromazine—Promazine—Diphenhydramine—atopic dermatitis	0.0697	0.168	CrCrCtD
Triflupromazine—ABCB1—Tacrolimus—atopic dermatitis	0.0469	0.0827	CbGbCtD
Triflupromazine—ABCB1—Loratadine—atopic dermatitis	0.0343	0.0605	CbGbCtD
Triflupromazine—ABCB1—Methylprednisolone—atopic dermatitis	0.0314	0.0553	CbGbCtD
Triflupromazine—ABCB1—Betamethasone—atopic dermatitis	0.0204	0.036	CbGbCtD
Triflupromazine—ABCB1—Prednisolone—atopic dermatitis	0.0201	0.0355	CbGbCtD
Triflupromazine—ABCB1—Hydrocortisone—atopic dermatitis	0.0191	0.0337	CbGbCtD
Triflupromazine—ABCB1—Prednisone—atopic dermatitis	0.019	0.0335	CbGbCtD
Triflupromazine—ABCB1—Dexamethasone—atopic dermatitis	0.0119	0.0209	CbGbCtD
Triflupromazine—HTR2B—GPCR downstream signaling—CXCR3—atopic dermatitis	3.09e-05	0.00172	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—CXCL10—atopic dermatitis	3.08e-05	0.00172	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—CXCL10—atopic dermatitis	3.04e-05	0.00169	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CCL27—atopic dermatitis	3.03e-05	0.00169	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—CCR3—atopic dermatitis	3.03e-05	0.00169	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—NPS—atopic dermatitis	2.97e-05	0.00166	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—TAC1—atopic dermatitis	2.97e-05	0.00166	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—IL5—atopic dermatitis	2.93e-05	0.00163	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—CXCR3—atopic dermatitis	2.91e-05	0.00162	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CCL17—atopic dermatitis	2.89e-05	0.00161	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—TAC1—atopic dermatitis	2.86e-05	0.00159	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—NPS—atopic dermatitis	2.86e-05	0.00159	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—CXCR3—atopic dermatitis	2.81e-05	0.00156	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—CCL11—atopic dermatitis	2.8e-05	0.00156	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—FCER2—atopic dermatitis	2.76e-05	0.00154	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—IL5—atopic dermatitis	2.76e-05	0.00154	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CCL11—atopic dermatitis	2.74e-05	0.00153	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CCL17—atopic dermatitis	2.72e-05	0.00152	CbGpPWpGaD
Triflupromazine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.72e-05	0.00152	CbGpPWpGaD
Triflupromazine—DRD2—GPCR ligand binding—CCL5—atopic dermatitis	2.71e-05	0.00151	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CCL11—atopic dermatitis	2.71e-05	0.00151	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—FCER2—atopic dermatitis	2.71e-05	0.00151	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—NPS—atopic dermatitis	2.7e-05	0.0015	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—TAC1—atopic dermatitis	2.7e-05	0.0015	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—FCER2—atopic dermatitis	2.67e-05	0.00149	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—IL5—atopic dermatitis	2.66e-05	0.00148	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—CCL5—atopic dermatitis	2.65e-05	0.00148	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—CXCR3—atopic dermatitis	2.65e-05	0.00147	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—CCL5—atopic dermatitis	2.62e-05	0.00146	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—KIF3A—atopic dermatitis	2.57e-05	0.00143	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCL22—atopic dermatitis	2.57e-05	0.00143	CbGpPWpGaD
Triflupromazine—DRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.57e-05	0.00143	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—CCR3—atopic dermatitis	2.52e-05	0.0014	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCL22—atopic dermatitis	2.52e-05	0.0014	CbGpPWpGaD
Triflupromazine—ABCB1—Allograft Rejection—TNF—atopic dermatitis	2.51e-05	0.0014	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—IL5—atopic dermatitis	2.51e-05	0.0014	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—CXCL10—atopic dermatitis	2.5e-05	0.00139	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	2.5e-05	0.00139	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCL22—atopic dermatitis	2.48e-05	0.00138	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—CCR3—atopic dermatitis	2.46e-05	0.00137	CbGpPWpGaD
Triflupromazine—DRD2—GPCR ligand binding—CCR5—atopic dermatitis	2.44e-05	0.00136	CbGpPWpGaD
Triflupromazine—DRD2—G alpha (i) signalling events—CXCL8—atopic dermatitis	2.44e-05	0.00136	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—CCR3—atopic dermatitis	2.43e-05	0.00136	CbGpPWpGaD
Triflupromazine—DRD2—Circadian rythm related genes—MAPK8—atopic dermatitis	2.43e-05	0.00135	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—KIF3A—atopic dermatitis	2.43e-05	0.00135	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	2.42e-05	0.00135	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—CCR5—atopic dermatitis	2.39e-05	0.00133	CbGpPWpGaD
Triflupromazine—CHRM1—Circadian rythm related genes—MAPK8—atopic dermatitis	2.38e-05	0.00132	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—CCR5—atopic dermatitis	2.36e-05	0.00131	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—CXCL10—atopic dermatitis	2.35e-05	0.00131	CbGpPWpGaD
Triflupromazine—CHRM2—G alpha (i) signalling events—CXCL8—atopic dermatitis	2.35e-05	0.00131	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CMA1—atopic dermatitis	2.33e-05	0.0013	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CCL11—atopic dermatitis	2.33e-05	0.0013	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	2.31e-05	0.00129	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCL27—atopic dermatitis	2.29e-05	0.00128	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—CCR3—atopic dermatitis	2.29e-05	0.00127	CbGpPWpGaD
Triflupromazine—CHRM2—SIDS Susceptibility Pathways—TNF—atopic dermatitis	2.27e-05	0.00127	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—CXCL10—atopic dermatitis	2.27e-05	0.00126	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	2.25e-05	0.00126	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—TAC1—atopic dermatitis	2.24e-05	0.00125	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—NPS—atopic dermatitis	2.24e-05	0.00125	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCL27—atopic dermatitis	2.24e-05	0.00125	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CCR3—atopic dermatitis	2.24e-05	0.00125	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCL27—atopic dermatitis	2.21e-05	0.00123	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CCR3—atopic dermatitis	2.21e-05	0.00123	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—CXCR3—atopic dermatitis	2.2e-05	0.00123	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—TAC1—atopic dermatitis	2.2e-05	0.00122	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—NPS—atopic dermatitis	2.2e-05	0.00122	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CMA1—atopic dermatitis	2.19e-05	0.00122	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CCL11—atopic dermatitis	2.19e-05	0.00122	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—STAT6—atopic dermatitis	2.19e-05	0.00122	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—TAC1—atopic dermatitis	2.17e-05	0.00121	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—NPS—atopic dermatitis	2.17e-05	0.00121	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	2.15e-05	0.0012	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—CCL5—atopic dermatitis	2.15e-05	0.0012	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—CXCL10—atopic dermatitis	2.14e-05	0.00119	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—CXCR3—atopic dermatitis	2.13e-05	0.00118	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—IL5—atopic dermatitis	2.09e-05	0.00116	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR ligand binding—CXCL8—atopic dermatitis	2.07e-05	0.00115	CbGpPWpGaD
Triflupromazine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	2.06e-05	0.00115	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—STAT6—atopic dermatitis	2.06e-05	0.00115	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCL17—atopic dermatitis	2.05e-05	0.00115	CbGpPWpGaD
Triflupromazine—DRD1—Circadian rythm related genes—IL6—atopic dermatitis	2.05e-05	0.00115	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—IL5—atopic dermatitis	2.04e-05	0.00114	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—TAC1—atopic dermatitis	2.04e-05	0.00114	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—NPS—atopic dermatitis	2.04e-05	0.00114	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—CCL5—atopic dermatitis	2.03e-05	0.00113	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—IL5—atopic dermatitis	2.01e-05	0.00112	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCL17—atopic dermatitis	2.01e-05	0.00112	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—CXCR3—atopic dermatitis	2e-05	0.00111	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—TAC1—atopic dermatitis	1.99e-05	0.00111	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—NPS—atopic dermatitis	1.99e-05	0.00111	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCL17—atopic dermatitis	1.98e-05	0.00111	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—TAC1—atopic dermatitis	1.97e-05	0.0011	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—NPS—atopic dermatitis	1.97e-05	0.0011	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CXCR3—atopic dermatitis	1.95e-05	0.00109	CbGpPWpGaD
Triflupromazine—DRD1—GPCR ligand binding—CXCL8—atopic dermatitis	1.95e-05	0.00109	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—CCL5—atopic dermatitis	1.95e-05	0.00109	CbGpPWpGaD
Triflupromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.94e-05	0.00108	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—CCR5—atopic dermatitis	1.94e-05	0.00108	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CXCR3—atopic dermatitis	1.93e-05	0.00108	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CCR3—atopic dermatitis	1.9e-05	0.00106	CbGpPWpGaD
Triflupromazine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.9e-05	0.00106	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—IL5—atopic dermatitis	1.89e-05	0.00106	CbGpPWpGaD
Triflupromazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.87e-05	0.00104	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—IL5—atopic dermatitis	1.85e-05	0.00103	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—CCL5—atopic dermatitis	1.84e-05	0.00103	CbGpPWpGaD
Triflupromazine—CHRM2—SIDS Susceptibility Pathways—IL6—atopic dermatitis	1.83e-05	0.00102	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—KIF3A—atopic dermatitis	1.83e-05	0.00102	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—IL5—atopic dermatitis	1.83e-05	0.00102	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—CCR5—atopic dermatitis	1.83e-05	0.00102	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—KIF3A—atopic dermatitis	1.79e-05	0.000999	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CCR3—atopic dermatitis	1.79e-05	0.000997	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—CXCL10—atopic dermatitis	1.78e-05	0.000991	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—KIF3A—atopic dermatitis	1.77e-05	0.000986	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—CCR5—atopic dermatitis	1.76e-05	0.00098	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	1.74e-05	0.00097	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—CXCL10—atopic dermatitis	1.72e-05	0.000958	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TAC1—atopic dermatitis	1.69e-05	0.000942	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—NPS—atopic dermatitis	1.69e-05	0.000942	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—CCR5—atopic dermatitis	1.66e-05	0.000924	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CXCR3—atopic dermatitis	1.66e-05	0.000924	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCL11—atopic dermatitis	1.66e-05	0.000923	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CMA1—atopic dermatitis	1.66e-05	0.000923	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CMA1—atopic dermatitis	1.62e-05	0.000903	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCL11—atopic dermatitis	1.62e-05	0.000903	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GLB1—atopic dermatitis	1.62e-05	0.000902	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—CXCL10—atopic dermatitis	1.61e-05	0.0009	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCL11—atopic dermatitis	1.6e-05	0.000892	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CMA1—atopic dermatitis	1.6e-05	0.000892	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—NPS—atopic dermatitis	1.59e-05	0.000888	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TAC1—atopic dermatitis	1.59e-05	0.000888	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CXCL10—atopic dermatitis	1.58e-05	0.000881	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IL5—atopic dermatitis	1.57e-05	0.000876	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	1.57e-05	0.000873	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CXCR3—atopic dermatitis	1.56e-05	0.000871	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CXCL10—atopic dermatitis	1.56e-05	0.00087	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—STAT6—atopic dermatitis	1.56e-05	0.000868	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—ADSL—atopic dermatitis	1.55e-05	0.000865	CbGpPWpGaD
Triflupromazine—DRD2—Circadian rythm related genes—IL6—atopic dermatitis	1.55e-05	0.000864	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—CCL5—atopic dermatitis	1.53e-05	0.000853	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—STAT6—atopic dermatitis	1.52e-05	0.000849	CbGpPWpGaD
Triflupromazine—CHRM1—Circadian rythm related genes—IL6—atopic dermatitis	1.52e-05	0.000846	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—STAT6—atopic dermatitis	1.5e-05	0.000839	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—CCL5—atopic dermatitis	1.5e-05	0.000835	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IL5—atopic dermatitis	1.48e-05	0.000826	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—CCL5—atopic dermatitis	1.48e-05	0.000824	CbGpPWpGaD
Triflupromazine—DRD2—GPCR ligand binding—CXCL8—atopic dermatitis	1.48e-05	0.000822	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR ligand binding—CXCL8—atopic dermatitis	1.44e-05	0.000805	CbGpPWpGaD
Triflupromazine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	1.44e-05	0.000802	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR ligand binding—CXCL8—atopic dermatitis	1.43e-05	0.000794	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—CCL5—atopic dermatitis	1.39e-05	0.000775	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—CCR5—atopic dermatitis	1.38e-05	0.000769	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CCL5—atopic dermatitis	1.36e-05	0.000758	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCR3—atopic dermatitis	1.35e-05	0.000753	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—CCR5—atopic dermatitis	1.35e-05	0.000752	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CCL5—atopic dermatitis	1.34e-05	0.000748	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CXCL10—atopic dermatitis	1.34e-05	0.000747	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—CCR5—atopic dermatitis	1.33e-05	0.000743	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCR3—atopic dermatitis	1.32e-05	0.000736	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism of proteins—CXCL8—atopic dermatitis	1.32e-05	0.000734	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCR3—atopic dermatitis	1.3e-05	0.000727	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CXCL10—atopic dermatitis	1.26e-05	0.000704	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—CCR5—atopic dermatitis	1.25e-05	0.000698	CbGpPWpGaD
Triflupromazine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.24e-05	0.000691	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CCR5—atopic dermatitis	1.23e-05	0.000683	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CCR5—atopic dermatitis	1.21e-05	0.000674	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TAC1—atopic dermatitis	1.2e-05	0.000671	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NPS—atopic dermatitis	1.2e-05	0.000671	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CXCR3—atopic dermatitis	1.18e-05	0.000658	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TAC1—atopic dermatitis	1.18e-05	0.000656	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NPS—atopic dermatitis	1.18e-05	0.000656	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—CXCL8—atopic dermatitis	1.17e-05	0.000653	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NPS—atopic dermatitis	1.16e-05	0.000648	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TAC1—atopic dermatitis	1.16e-05	0.000648	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CXCR3—atopic dermatitis	1.15e-05	0.000644	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CCL5—atopic dermatitis	1.15e-05	0.000643	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CXCR3—atopic dermatitis	1.14e-05	0.000635	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.12e-05	0.000625	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—IL2—atopic dermatitis	1.12e-05	0.000624	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IL5—atopic dermatitis	1.12e-05	0.000624	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.1e-05	0.000615	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IL5—atopic dermatitis	1.09e-05	0.00061	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CCL5—atopic dermatitis	1.09e-05	0.000606	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IL5—atopic dermatitis	1.08e-05	0.000602	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PPARA—atopic dermatitis	1.08e-05	0.0006	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—NGF—atopic dermatitis	1.07e-05	0.000595	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—CXCL8—atopic dermatitis	1.06e-05	0.000593	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—IL2—atopic dermatitis	1.06e-05	0.000588	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CCR5—atopic dermatitis	1.04e-05	0.000579	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—IL2—atopic dermatitis	1.02e-05	0.000566	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—NGF—atopic dermatitis	1.01e-05	0.000561	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—CXCL8—atopic dermatitis	1e-05	0.000559	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CCR5—atopic dermatitis	9.8e-06	0.000546	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—IL2—atopic dermatitis	9.58e-06	0.000534	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CXCL10—atopic dermatitis	9.54e-06	0.000532	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CXCL10—atopic dermatitis	9.33e-06	0.00052	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CXCL10—atopic dermatitis	9.21e-06	0.000514	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—NFKBIA—atopic dermatitis	8.81e-06	0.000491	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—CXCL8—atopic dermatitis	8.34e-06	0.000465	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—NFKBIA—atopic dermatitis	8.31e-06	0.000463	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCL5—atopic dermatitis	8.21e-06	0.000458	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	8.16e-06	0.000455	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—CXCL8—atopic dermatitis	8.05e-06	0.000449	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCL5—atopic dermatitis	8.04e-06	0.000448	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—IL2—atopic dermatitis	7.97e-06	0.000444	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCL5—atopic dermatitis	7.93e-06	0.000442	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—IL2—atopic dermatitis	7.8e-06	0.000435	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—IL2—atopic dermatitis	7.7e-06	0.000429	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NGF—atopic dermatitis	7.6e-06	0.000424	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—CXCL8—atopic dermatitis	7.57e-06	0.000422	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NGF—atopic dermatitis	7.44e-06	0.000415	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CXCL8—atopic dermatitis	7.41e-06	0.000413	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CCR5—atopic dermatitis	7.4e-06	0.000412	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NGF—atopic dermatitis	7.35e-06	0.000409	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CXCL8—atopic dermatitis	7.31e-06	0.000408	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CCR5—atopic dermatitis	7.24e-06	0.000404	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—IL2—atopic dermatitis	7.23e-06	0.000403	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CCR5—atopic dermatitis	7.15e-06	0.000398	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—IL2—atopic dermatitis	7.08e-06	0.000395	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—IL2—atopic dermatitis	6.99e-06	0.00039	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CXCL8—atopic dermatitis	6.28e-06	0.00035	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NFKBIA—atopic dermatitis	6.27e-06	0.00035	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NFKBIA—atopic dermatitis	6.14e-06	0.000342	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NFKBIA—atopic dermatitis	6.06e-06	0.000338	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IL2—atopic dermatitis	6e-06	0.000335	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—IL6—atopic dermatitis	5.97e-06	0.000333	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CXCL8—atopic dermatitis	5.92e-06	0.00033	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IL2—atopic dermatitis	5.66e-06	0.000316	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—IL6—atopic dermatitis	5.63e-06	0.000314	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MAPK8—atopic dermatitis	5.52e-06	0.000308	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PPARA—atopic dermatitis	5.25e-06	0.000293	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MAPK8—atopic dermatitis	5.21e-06	0.00029	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CXCL8—atopic dermatitis	4.47e-06	0.000249	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CXCL8—atopic dermatitis	4.38e-06	0.000244	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CXCL8—atopic dermatitis	4.32e-06	0.000241	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IL2—atopic dermatitis	4.27e-06	0.000238	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—IL6—atopic dermatitis	4.25e-06	0.000237	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IL2—atopic dermatitis	4.18e-06	0.000233	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—IL6—atopic dermatitis	4.16e-06	0.000232	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IL2—atopic dermatitis	4.13e-06	0.00023	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—IL6—atopic dermatitis	4.11e-06	0.000229	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MAPK8—atopic dermatitis	3.93e-06	0.000219	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MAPK8—atopic dermatitis	3.85e-06	0.000215	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MAPK8—atopic dermatitis	3.8e-06	0.000212	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IL6—atopic dermatitis	3.53e-06	0.000197	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IL6—atopic dermatitis	3.33e-06	0.000185	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IL6—atopic dermatitis	2.51e-06	0.00014	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IL6—atopic dermatitis	2.46e-06	0.000137	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IL6—atopic dermatitis	2.43e-06	0.000135	CbGpPWpGaD
